Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Fiscal Policy is one of the most influential pillars of India’s economic strategy. It determines…
The Earth has many amazing and unusual places, and some of them experience temperatures that…
In a striking reflection of a shifting global wealth landscape, the UBS Billionaire Ambitions Report…
In a landmark moment for cricket, Sunil Narine has become the first player in the…
Russia’s S-500 Missile System, officially known as 55R6M “Triumfator-M” or Prometey, is shaping the future…
India–Russia relations continue to evolve in a changing global order. Ahead of President Vladimir Putin’s…